ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36154
-0.01%
Bitcoin
66,346.41
-0.89%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pharming Group NV (PHAR)

  7. Pharming Group NV (PHAR) News

PHAR

Pharming Group NV (PHAR)

Pharming Group NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHAR
DateTimeSourceHeadlineSymbolCompany
05/15/202410:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHARPharming Group NV
05/08/20245:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHARPharming Group NV
01/08/20248:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHARPharming Group NV
10/26/20238:25AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHARPharming Group NV
08/24/20231:00AMPR Newswire (US)Pharming Group to participate in September investor conferencesNASDAQ:PHARPharming Group NV
08/14/202312:00AMPR Newswire (US)Pharming Group to convene Extraordinary General Meeting of ShareholdersNASDAQ:PHARPharming Group NV
08/09/202312:00AMPR Newswire (US)Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in JapanNASDAQ:PHARPharming Group NV
08/09/202312:00AMPR Newswire (US)Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in JapanNASDAQ:PHARPharming Group NV
08/03/202310:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHARPharming Group NV
08/03/202312:00AMPR Newswire (US)Pharming Group reports second quarter and first half 2023 financial resultsNASDAQ:PHARPharming Group NV
07/18/202312:00AMPR Newswire (US)Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the BoardNASDAQ:PHARPharming Group NV
07/18/202312:00AMPR Newswire (US)Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the BoardNASDAQ:PHARPharming Group NV
07/13/20231:00AMPR Newswire (US)Pharming Group to report second quarter and first half 2023 financial results on August 3NASDAQ:PHARPharming Group NV
07/13/20231:00AMPR Newswire (US)Pharming Group to report second quarter and first half 2023 financial results on August 3NASDAQ:PHARPharming Group NV
06/01/20235:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PHARPharming Group NV
06/01/202312:00AMPR Newswire (US)Pharming announces sale of priority review voucherNASDAQ:PHARPharming Group NV
06/01/202312:00AMPR Newswire (US)Pharming announces sale of priority review voucherNASDAQ:PHARPharming Group NV
05/25/20231:00AMPR Newswire (US)Pharming Group to attend the following Investor Conferences in JuneNASDAQ:PHARPharming Group NV
05/25/20231:00AMPR Newswire (US)Pharming Group to attend the following Investor Conferences in JuneNASDAQ:PHARPharming Group NV
05/17/202310:28AMPR Newswire (US)Pharming Group reports on results of the 2023 Annual General Meeting of ShareholdersNASDAQ:PHARPharming Group NV
05/11/202312:00AMPR Newswire (US)Pharming Group reports financial results for the first quarter of 2023NASDAQ:PHARPharming Group NV
05/11/202312:00AMPR Newswire (US)Pharming Group reports financial results for the first quarter of 2023NASDAQ:PHARPharming Group NV
04/26/20231:00AMPR Newswire (US)Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023NASDAQ:PHARPharming Group NV
04/19/20231:00AMPR Newswire (US)Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023NASDAQ:PHARPharming Group NV
04/19/202312:36AMPR Newswire (US)Notice of First Quarter 2023 ResultsNASDAQ:PHARPharming Group NV
04/13/20236:11AMPR Newswire (US)Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023NASDAQ:PHARPharming Group NV
04/11/20237:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PHARPharming Group NV
04/11/202312:00AMPR Newswire (US)Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.NASDAQ:PHARPharming Group NV
04/11/202312:00AMPR Newswire (Canada)Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.NASDAQ:PHARPharming Group NV
04/11/202312:00AMPR Newswire (US)Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.NASDAQ:PHARPharming Group NV
 Showing the most relevant articles for your search:NASDAQ:PHAR

Your Recent History

AMEX
BXL
Bexil
HUOB
ONTBTC
Ontology
NASDAQ
PLMIW
Plum Acquisition Corpora...
COIN
GFNCASHGBP
USOTC
SNPHY
Santen Pharmaceutical (PK)
USOTC
SYVN
Sycamore Ventures (CE)
EU
AKW
Mgi Coutier
BIT
ECOM
L&G ETFS Ecommerce Logis...
GATE
HYDRAUSDT
Hydra
KOSPI
042700
Hanmi Semiconductor
NASDAQ
PTEKD
LSE
IPOL
Ishr Msci Pol
AMEX
ZROZ
PIMCO 25 Plus Yr Zero Co...
ASX
CKK
Coretrack
AMEX
TRE
Tan Range Exploratio
COIN
KITTEEUST
KITTEE
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved